Your browser doesn't support javascript.
loading
Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment.
Ghiti Moghadam, Marjan; Lamers-Karnebeek, Femke B G; Vonkeman, Harald E; Ten Klooster, Peter M; Tekstra, Janneke; Schilder, Annemarie M; Visser, Henk; Sasso, Eric H; Chernoff, David; Lems, Willem F; van Schaardenburg, Dirk-Jan; Landewe, Robert; Bernelot Moens, Hein J; Radstake, Timothy R D J; van Riel, Piet L C M; van de Laar, Mart A F J; Jansen, Tim L.
Afiliação
  • Ghiti Moghadam M; Department of Rheumatology, Medisch Spectrum Twente, Enschede, The Netherlands.
  • Lamers-Karnebeek FBG; Department of Psychology, Health & Technology, University of Twente, Enschede, The Netherlands.
  • Vonkeman HE; Department of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Ten Klooster PM; Department of Rheumatology, Medisch Spectrum Twente, Enschede, The Netherlands.
  • Tekstra J; Department of Psychology, Health & Technology, University of Twente, Enschede, The Netherlands.
  • Schilder AM; Department of Psychology, Health & Technology, University of Twente, Enschede, The Netherlands.
  • Visser H; Department of Rheumatology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Sasso EH; Department of Rheumatology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.
  • Chernoff D; Department of Rheumatology, Rijnstate, Arnhem, The Netherlands.
  • Lems WF; Crescendo Bioscience, Inc., South San Francisco, CA, United States of America.
  • van Schaardenburg DJ; Crescendo Bioscience, Inc., South San Francisco, CA, United States of America.
  • Landewe R; Department of Rheumatology, VU University Medical Center, Amsterdam, The Netherlands.
  • Bernelot Moens HJ; Department of Rheumatology, Jan van Breemen Research Institute/Reade, Amsterdam, the Netherlands.
  • Radstake TRDJ; Department of Rheumatology, AMC Amsterdam, Amsterdam, the Netherlands.
  • van Riel PLCM; Department of Rheumatology, Ziekenhuis Groep Twente, Hengelo, The Netherlands.
  • van de Laar MAFJ; Department of Rheumatology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Jansen TL; Department of IQ Healthcare, Radboud University Medical Center, Nijmegen, The Netherlands.
PLoS One ; 13(5): e0192425, 2018.
Article em En | MEDLINE | ID: mdl-29791439

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Fator de Necrose Tumoral alfa / Suspensão de Tratamento Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Fator de Necrose Tumoral alfa / Suspensão de Tratamento Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Ano de publicação: 2018 Tipo de documento: Article